These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients. van der Poel HG Eur Urol; 2009 May; 55(5):1133-4. PubMed ID: 18585847 [No Abstract] [Full Text] [Related]
4. Editorial comment to comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis. Costantini E; Mearini L Int J Urol; 2012 Sep; 19(9):844-5. PubMed ID: 22640746 [No Abstract] [Full Text] [Related]
5. Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients. Berney DM Eur Urol; 2009 May; 55(5):1134. PubMed ID: 18585844 [No Abstract] [Full Text] [Related]
7. Reply: To PMID 24962844. Froehner M; Koch R; Hübler M; Litz R; Wirth MP Urology; 2014 Aug; 84(2):312-3. PubMed ID: 24962846 [No Abstract] [Full Text] [Related]
8. Survival analysis in men undergoing radical prostatectomy at an age of 70 years or older. Froehner M; Koch R; Litz RJ; Hakenberg OW; Oehlschlaeger S; Wirth MP Urol Oncol; 2010; 28(6):628-34. PubMed ID: 19117769 [TBL] [Abstract][Full Text] [Related]
11. Propensity score matching, competing risk analysis, and a competing risk nomogram: some guidance for urologists may be in place. Roobol MJ; Heijnsdijk EA Eur Urol; 2011 Nov; 60(5):931-3; discussion 933-4. PubMed ID: 21802834 [No Abstract] [Full Text] [Related]
17. Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No. Ristau BT; Smaldone MC Int Braz J Urol; 2016; 42(5):880-882. PubMed ID: 27716457 [No Abstract] [Full Text] [Related]
18. Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: Yes. Costa WH; Guimarães GC Int Braz J Urol; 2016; 42(5):876-879. PubMed ID: 27716456 [No Abstract] [Full Text] [Related]
19. Re: 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity. Russo A; Autelitano M; Bisanti L J Natl Cancer Inst; 2006 Mar; 98(6):421; author reply 421-2. PubMed ID: 16537836 [No Abstract] [Full Text] [Related]
20. Editorial comment on: poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men. Barry MJ Eur Urol; 2008 Jul; 54(1):116-7. PubMed ID: 17996360 [No Abstract] [Full Text] [Related] [Next] [New Search]